Index S&P 500
P/E 20.53
EPS (ttm) 6.95
Insider Own 0.85%
Shs Outstand 325.91M
Perf Week 1.68%
Market Cap 46.52B
Forward P/E 22.22
EPS next Y 6.42
Insider Trans 0.16%
Shs Float 323.13M
Perf Month -5.27%
Income 2.30B
PEG 2.39
EPS next Q 1.36
Inst Own 91.09%
Short Float 1.48%
Perf Quarter -0.07%
Sales 5.66B
P/S 8.22
EPS this Y -11.12%
Inst Trans -1.81%
Short Ratio 3.16
Perf Half Y 34.69%
Book/sh 9.15
P/B 15.60
EPS next Y 3.56%
ROA 6.87%
Short Interest 4.78M
Perf Year 30.68%
Cash/sh 6.66
P/C 21.45
EPS next 5Y 8.60%
ROE 75.03%
52W Range 100.17 - 157.82
Perf YTD 0.06%
Dividend Est. 7.87 (5.52% )
P/FCF 12.95
EPS past 5Y 0.03%
ROI 8.64%
52W High -9.56%
Beta 1.70
Dividend TTM 7.60 (5.32% )
Quick Ratio -
Sales past 5Y 0.64%
Gross Margin 59.52%
52W Low 42.49%
ATR (14) 2.91
Dividend Ex-Date Mar 07, 2024
Current Ratio -
EPS Y/Y TTM 3.94%
Oper. Margin 49.60%
RSI (14) 41.44
Volatility 1.73% 1.87%
Employees 3000
Debt/Eq 8.78
Sales Y/Y TTM 6.93%
Profit Margin 40.64%
Recom 2.26
Target Price 157.06
Option/Short Yes / Yes
LT Debt/Eq 7.80
EPS Q/Q 12.65%
Payout 107.21%
Rel Volume 1.03
Prev Close 142.81
Sales Surprise 10.76%
EPS Surprise 21.56%
Sales Q/Q 9.05%
Earnings May 06 AMC
Avg Volume 1.51M
Price 142.73
SMA20 -2.69%
SMA50 -4.14%
SMA200 9.93%
Trades
Volume 1,741,248
Change -0.06%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-21-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$132 → $143
Aug-03-23 Downgrade
Evercore ISI
Outperform → In-line
$131 → $129
Jul-06-23 Upgrade
Wolfe Research
Peer Perform → Outperform
$127
Mar-21-23 Resumed
Goldman
Buy
$150
Oct-18-22 Initiated
Wolfe Research
Peer Perform
Jun-30-22 Downgrade
Jefferies
Buy → Hold
$100
Sep-22-21 Upgrade
Argus
Hold → Buy
$142
Aug-04-21 Upgrade
BofA Securities
Neutral → Buy
$141 → $150
Jul-20-21 Upgrade
Stifel
Hold → Buy
$125 → $132
Jun-04-21 Initiated
UBS
Neutral
$135
Apr-26-21 Upgrade
Evercore ISI
In-line → Outperform
$112 → $128
Apr-16-21 Upgrade
Jefferies
Hold → Buy
$112 → $130
Feb-23-21 Resumed
Citigroup
Neutral
$49 → $110
Feb-11-21 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$88 → $125
Jan-06-21 Initiated
Evercore ISI
In-line
$89
Dec-16-20 Downgrade
Edward Jones
Hold → Sell
Dec-02-20 Downgrade
Argus
Buy → Hold
Jul-01-20 Resumed
Goldman
Buy
$94
Jun-04-20 Initiated
Compass Point
Buy
$120
May-07-20 Downgrade
Wells Fargo
Overweight → Equal Weight
$130 → $60
Show Previous Ratings
Apr-24-24 12:00PM
07:37AM
07:36AM
Apr-22-24 07:10PM
(The Wall Street Journal)
04:33PM
05:42PM
Loading…
Apr-18-24 05:42PM
Apr-16-24 12:50PM
Apr-14-24 11:37AM
Apr-11-24 04:10PM
Apr-10-24 01:17PM
(The Wall Street Journal)
09:00AM
06:22AM
Apr-08-24 06:00PM
Apr-05-24 09:49AM
Apr-04-24 06:15PM
11:22AM
Loading…
11:22AM
Apr-01-24 08:18PM
Mar-25-24 12:00PM
Mar-23-24 02:00PM
Mar-21-24 06:15PM
Mar-19-24 02:07PM
01:57PM
Mar-15-24 06:00PM
Mar-13-24 06:15PM
Mar-08-24 09:00PM
(The Wall Street Journal)
Mar-07-24 06:27AM
Mar-06-24 01:25PM
Mar-05-24 11:29AM
Mar-01-24 11:11AM
Feb-29-24 04:10PM
02:27PM
Loading…
02:27PM
Feb-28-24 12:32PM
11:52AM
Feb-26-24 06:03PM
Feb-23-24 05:30PM
Feb-17-24 07:00AM
Feb-16-24 12:26PM
Feb-14-24 10:00AM
06:05AM
Feb-12-24 09:46AM
Feb-09-24 11:25AM
06:40AM
Feb-08-24 04:15PM
Feb-06-24 03:09PM
(Thomson Reuters StreetEvents)
12:40PM
11:19AM
10:26AM
10:14AM
08:34AM
Feb-05-24 11:30PM
06:04PM
06:00PM
05:23PM
05:15PM
04:35PM
04:23PM
(Associated Press Finance)
04:05PM
Feb-01-24 06:00PM
09:48AM
Jan-31-24 09:15AM
Jan-29-24 05:15PM
04:19PM
Jan-26-24 06:00PM
Jan-24-24 06:15PM
Jan-18-24 06:15PM
01:20PM
11:10AM
Jan-17-24 08:50AM
(Investor's Business Daily)
Jan-16-24 11:30AM
Jan-12-24 10:04AM
Jan-11-24 06:15PM
Jan-10-24 04:10PM
Jan-09-24 04:36PM
Jan-05-24 06:15PM
Dec-28-23 06:15PM
09:06AM
Dec-21-23 03:01AM
Dec-19-23 06:00PM
10:00AM
Dec-18-23 06:15PM
05:39AM
Dec-15-23 07:23AM
Dec-14-23 07:16PM
(Morningstar Research) +5.26%
Dec-13-23 03:37PM
Dec-12-23 06:00PM
Dec-06-23 05:11AM
Nov-30-23 04:15PM
08:27AM
Nov-29-23 11:30AM
Nov-22-23 10:20AM
06:55AM
Nov-17-23 02:57PM
09:29AM
08:45AM
06:28AM
Nov-16-23 12:56PM
Nov-07-23 04:26PM
04:07PM
Nov-06-23 06:00PM
Nov-01-23 12:00PM
Simon Property Group, Inc. is a self-administered and self-managed real estate investment trust, which engages in the ownership, development, and management of shopping, dining, entertainment, and mixed-used destinations, which consist primarily of malls, Premium Outlets, and the Mills. The company was founded by Fred Simon, Herbert Simon and Melvin Simon in 1993 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LEIBOWITZ REUBEN S Director Apr 01 '24 Buy 154.19 438 67,535 53,116 Apr 02 03:56 PM HUBBARD ALLAN B Director Apr 01 '24 Buy 154.19 357 55,046 32,222 Apr 02 03:52 PM GLASSCOCK LARRY C Director Apr 01 '24 Buy 154.19 321 49,495 38,541 Apr 02 03:50 PM Smith Daniel C. Director Apr 01 '24 Buy 154.19 310 47,799 27,829 Apr 02 04:09 PM RODKIN GARY M Director Apr 01 '24 Buy 154.19 192 29,604 15,497 Apr 02 04:02 PM Aeppel Glyn Director Apr 01 '24 Buy 154.19 181 27,908 15,502 Apr 02 03:44 PM SELIG STEFAN M Director Apr 01 '24 Buy 154.19 166 25,596 28,367 Apr 02 04:07 PM STEWART MARTA R Director Apr 01 '24 Buy 154.19 156 24,054 12,584 Apr 02 04:12 PM Roe Peggy Fang Director Apr 01 '24 Buy 154.19 48 7,401 3,898 Apr 02 04:04 PM LEWIS RANDALL J Director Apr 01 '24 Buy 154.19 24 3,701 1,927 Apr 02 03:58 PM Jones Nina P Director Apr 01 '24 Buy 154.19 5 771 401 Apr 02 03:54 PM LEIBOWITZ REUBEN S Director Dec 29 '23 Buy 143.85 451 64,876 50,178 Jan 02 04:44 PM HUBBARD ALLAN B Director Dec 29 '23 Buy 143.85 367 52,793 31,865 Jan 02 04:32 PM GLASSCOCK LARRY C Director Dec 29 '23 Buy 143.85 332 47,758 38,220 Jan 02 04:30 PM Smith Daniel C. Director Dec 29 '23 Buy 143.85 320 46,032 27,519 Jan 02 04:40 PM RODKIN GARY M Director Dec 29 '23 Buy 143.85 199 28,626 15,305 Jan 02 04:36 PM Aeppel Glyn Director Dec 29 '23 Buy 143.85 186 26,756 15,321 Jan 02 04:28 PM SELIG STEFAN M Director Dec 29 '23 Buy 143.85 172 24,742 28,201 Jan 02 04:39 PM STEWART MARTA R Director Dec 29 '23 Buy 143.85 161 23,160 12,428 Jan 02 04:42 PM Roe Peggy Fang Director Dec 29 '23 Buy 143.85 49 7,049 3,850 Jan 02 04:38 PM LEWIS RANDALL J Director Dec 29 '23 Buy 143.85 24 3,452 1,903 Jan 02 04:34 PM LEIBOWITZ REUBEN S Director Sep 29 '23 Buy 110.04 580 63,823 49,727 Oct 03 01:09 PM HUBBARD ALLAN B Director Sep 29 '23 Buy 110.04 472 51,939 31,498 Oct 03 12:56 PM GLASSCOCK LARRY C Director Sep 29 '23 Buy 110.04 427 46,987 37,888 Oct 03 12:55 PM Smith Daniel C. Director Sep 29 '23 Buy 110.04 411 45,226 27,199 Oct 03 01:03 PM McDade Brian J. EVP/CFO Sep 29 '23 Buy 109.19 359 39,199 25,741 Oct 03 02:17 PM RODKIN GARY M Director Sep 29 '23 Buy 110.04 255 28,060 15,106 Oct 03 12:59 PM Aeppel Glyn Director Sep 29 '23 Buy 110.04 239 26,300 15,135 Oct 03 12:53 PM SELIG STEFAN M Director Sep 29 '23 Buy 110.04 221 24,319 28,029 Oct 03 01:02 PM STEWART MARTA R Director Sep 29 '23 Buy 110.04 208 22,888 12,267 Oct 03 01:08 PM Roe Peggy Fang Director Sep 29 '23 Buy 110.04 63 6,933 3,801 Oct 03 01:00 PM LEWIS RANDALL J Director Sep 29 '23 Buy 110.04 31 3,411 1,879 Oct 03 12:57 PM LEIBOWITZ REUBEN S Director Jun 30 '23 Buy 116.16 526 61,100 49,147 Jul 05 01:27 PM HUBBARD ALLAN B Director Jun 30 '23 Buy 116.16 429 49,833 31,026 Jul 05 01:26 PM GLASSCOCK LARRY C Director Jun 30 '23 Buy 116.16 387 44,954 37,461 Jul 05 01:24 PM Smith Daniel C. Director Jun 30 '23 Buy 116.16 373 43,328 26,788 Jul 05 01:35 PM RODKIN GARY M Director Jun 30 '23 Buy 116.16 231 26,833 14,851 Jul 05 01:31 PM Aeppel Glyn Director Jun 30 '23 Buy 116.16 217 25,207 14,896 Jul 05 01:19 PM SELIG STEFAN M Director Jun 30 '23 Buy 116.16 200 23,232 27,808 Jul 05 01:34 PM STEWART MARTA R Director Jun 30 '23 Buy 116.16 188 21,838 12,059 Jul 05 01:39 PM Roe Peggy Fang Director Jun 30 '23 Buy 116.16 57 6,621 3,738 Jul 05 01:32 PM LEWIS RANDALL J Director Jun 30 '23 Buy 116.16 28 3,252 1,848 Jul 05 01:29 PM
Index S&P 500
P/E 24.50
EPS (ttm) 4.89
Insider Own 0.13%
Shs Outstand 205.60M
Perf Week 0.35%
Market Cap 24.56B
Forward P/E 13.78
EPS next Y 8.69
Insider Trans -8.80%
Shs Float 204.81M
Perf Month -6.35%
Income 1.02B
PEG 3.54
EPS next Q 1.87
Inst Own 91.11%
Short Float 2.07%
Perf Quarter -1.81%
Sales 7.39B
P/S 3.32
EPS this Y 6.81%
Inst Trans -0.06%
Short Ratio 3.07
Perf Half Y 14.22%
Book/sh 60.70
P/B 1.97
EPS next Y 7.73%
ROA 4.81%
Short Interest 4.25M
Perf Year -13.89%
Cash/sh 2.03
P/C 59.06
EPS next 5Y 6.93%
ROE 8.36%
52W Range 102.00 - 149.25
Perf YTD -1.60%
Dividend Est. 0.85 (0.71%)
P/FCF 25.09
EPS past 5Y -
ROI 5.84%
52W High -19.77%
Beta 1.04
Dividend TTM 0.96 (0.80%)
Quick Ratio 0.78
Sales past 5Y -1.20%
Gross Margin 63.02%
52W Low 17.40%
ATR (14) 2.25
Dividend Ex-Date Mar 27, 2024
Current Ratio 1.61
EPS Y/Y TTM 344.85%
Oper. Margin 18.67%
RSI (14) 35.43
Volatility 1.46% 1.86%
Employees 18000
Debt/Eq 0.48
Sales Y/Y TTM 6.55%
Profit Margin 13.85%
Recom 2.57
Target Price 136.55
Option/Short Yes / Yes
LT Debt/Eq 0.40
EPS Q/Q 423.09%
Payout 19.66%
Rel Volume 0.78
Prev Close 121.17
Sales Surprise 0.61%
EPS Surprise 2.15%
Sales Q/Q 6.30%
Earnings May 02 BMO
Avg Volume 1.38M
Price 119.75
SMA20 -4.70%
SMA50 -4.92%
SMA200 -0.99%
Trades
Volume 1,078,820
Change -1.17%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$135 → $125
Oct-20-23 Initiated
ROTH MKM
Neutral
$120
Aug-28-23 Upgrade
BTIG Research
Neutral → Buy
$139
May-03-23 Upgrade
BofA Securities
Underperform → Neutral
Apr-11-23 Upgrade
Evercore ISI
In-line → Outperform
$135 → $148
Mar-31-23 Upgrade
Jefferies
Underperform → Hold
$115 → $130
Mar-29-23 Initiated
UBS
Sell
$112
Mar-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$135 → $145
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$125 → $141
Jan-05-23 Upgrade
Raymond James
Mkt Perform → Outperform
$144
Jan-03-23 Downgrade
Evercore ISI
Outperform → In-line
$130
Nov-23-22 Upgrade
Wells Fargo
Underweight → Equal Weight
Oct-18-22 Initiated
Barclays
Underweight
$104
Oct-12-22 Initiated
Jefferies
Underperform
$95
May-27-22 Downgrade
Needham
Buy → Hold
Apr-13-22 Downgrade
Truist
Buy → Hold
$128 → $142
Apr-01-22 Downgrade
Citigroup
Buy → Neutral
$125.15 → $135
Mar-02-22 Resumed
BofA Securities
Underperform
$120
Mar-02-22 Downgrade
Loop Capital
Buy → Hold
$130
Feb-08-22 Reiterated
Wells Fargo
Underweight
$124 → $111
Show Previous Ratings
Apr-25-24 10:01AM
Apr-19-24 10:27AM
Apr-10-24 09:40AM
Apr-04-24 07:30AM
Apr-03-24 07:30AM
12:23PM
Loading…
Mar-27-24 12:23PM
Mar-13-24 04:30PM
Mar-11-24 08:25AM
Mar-08-24 11:29PM
Feb-29-24 09:40AM
Feb-22-24 07:30AM
05:25AM
Feb-21-24 07:35PM
07:17AM
07:00AM
01:26PM
Loading…
Feb-18-24 01:26PM
Feb-15-24 06:09AM
Feb-14-24 06:10AM
(Thomson Reuters StreetEvents)
Feb-12-24 09:40AM
07:30AM
07:00AM
Feb-08-24 02:24PM
10:08AM
09:30AM
08:21AM
07:40AM
06:54AM
06:41AM
06:39AM
(Associated Press Finance)
06:30AM
06:09AM
Loading…
06:09AM
06:09AM
Feb-05-24 09:16AM
Jan-23-24 06:13AM
Jan-22-24 10:42AM
Jan-16-24 07:30AM
Jan-10-24 12:00AM
Jan-05-24 07:30AM
Dec-28-23 10:49AM
Dec-27-23 07:50PM
Dec-19-23 07:30AM
05:00AM
Dec-15-23 07:18AM
(Thomson Reuters StreetEvents)
Dec-14-23 07:00AM
Dec-07-23 11:31AM
Nov-29-23 11:34AM
Nov-24-23 09:50AM
Nov-22-23 09:43PM
Nov-21-23 08:52AM
Nov-16-23 07:30AM
Nov-13-23 02:28PM
Nov-08-23 05:44PM
Nov-07-23 01:37PM
10:49AM
09:30AM
07:40AM
07:20AM
07:16AM
06:55AM
06:45AM
06:38AM
(Associated Press Finance)
06:30AM
Nov-06-23 09:51AM
Nov-05-23 11:17PM
Nov-02-23 11:45AM
09:21AM
Oct-31-23 10:01AM
Oct-30-23 11:31AM
09:00AM
Oct-26-23 11:52AM
Oct-25-23 11:40AM
Oct-20-23 09:37AM
08:45AM
Oct-18-23 12:06PM
Oct-13-23 07:57AM
Oct-12-23 01:52PM
08:14AM
Oct-11-23 11:37AM
Oct-10-23 07:00AM
Oct-05-23 03:28PM
Sep-29-23 12:20PM
08:32AM
Sep-26-23 07:34PM
Sep-14-23 09:40AM
Sep-06-23 04:07PM
(Investor's Business Daily)
11:33AM
Sep-05-23 04:30PM
10:38AM
Sep-03-23 10:30AM
Aug-30-23 09:32AM
Aug-28-23 09:58AM
02:39AM
Aug-27-23 01:54PM
Aug-25-23 05:00PM
Aug-23-23 07:30AM
Aug-22-23 07:38PM
11:38AM
08:20AM
Aug-15-23 10:56AM
(Thomson Reuters StreetEvents)
Aug-12-23 11:05AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Winkler Lori SVP and CHRO Apr 01 '24 Option Exercise 0.00 772 0 3,551 Apr 03 04:35 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Option Exercise 91.53 1,705 156,059 19,884 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Sale 126.86 1,705 216,296 18,179 Mar 08 05:03 PM Upadhyay Suketu Exec. VP, CFO Mar 06 '24 Option Exercise 0.00 4,561 0 22,683 Mar 08 05:05 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '24 Option Exercise 0.00 2,163 0 7,427 Mar 08 05:05 PM Winkler Lori SVP and CHRO Mar 06 '24 Option Exercise 0.00 1,757 0 3,207 Mar 08 05:05 PM Bezjak Mark President, Americas Mar 06 '24 Option Exercise 0.00 1,622 0 4,753 Mar 08 05:03 PM Ellingson Rachel SVP & Chief Strategy Officer Mar 06 '24 Option Exercise 0.00 1,419 0 7,291 Mar 08 05:03 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 06 '24 Option Exercise 0.00 2,095 0 50,046 Mar 08 05:03 PM Stellato Paul A VP, Controller & CAO Mar 06 '24 Option Exercise 0.00 609 0 1,176 Mar 08 05:04 PM Tornos Ivan President & CEO Mar 06 '24 Option Exercise 0.00 10,270 0 32,395 Mar 08 05:04 PM Yi Sang Group President, Asia Pacific Mar 06 '24 Option Exercise 0.00 2,365 0 18,179 Mar 08 05:03 PM Winkler Lori SVP and CHRO Mar 02 '24 Option Exercise 0.00 186 0 1,496 Mar 05 04:58 PM Yi Sang Group President, Asia Pacific Mar 01 '24 Option Exercise 0.00 2,052 0 15,814 Mar 05 04:59 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 01 '24 Option Exercise 0.00 1,641 0 48,597 Mar 05 05:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 25 '24 Option Exercise 0.00 4,580 0 48,725 Feb 27 08:57 PM Tornos Ivan President & CEO Feb 25 '24 Option Exercise 0.00 7,513 0 25,153 Feb 27 08:58 PM Upadhyay Suketu Exec. VP, CFO Feb 25 '24 Option Exercise 0.00 7,043 0 20,213 Feb 27 08:58 PM Bezjak Mark President, Americas Feb 25 '24 Option Exercise 0.00 1,528 0 3,535 Feb 27 08:56 PM Winkler Lori SVP and CHRO Feb 25 '24 Option Exercise 0.00 1,294 0 1,661 Feb 27 08:56 PM Ellingson Rachel SVP & Chief Strategy Officer Feb 25 '24 Option Exercise 0.00 1,762 0 6,460 Feb 27 08:57 PM Yi Sang Group President, Asia Pacific Feb 25 '24 Option Exercise 0.00 5,047 0 13,762 Feb 27 08:55 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Option Exercise 91.53 26,156 2,394,059 70,301 Feb 26 06:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Sale 128.62 26,156 3,364,126 44,145 Feb 26 06:02 PM Jafry Syed A. Director Nov 09 '23 Buy 104.75 2,135 223,641 4,060 Nov 13 04:02 PM Kolli Sreelakshmi Director Aug 30 '23 Buy 120.37 1,000 120,370 1,000 Sep 01 04:01 PM HAGEMANN ROBERT Director Aug 28 '23 Buy 116.48 2,000 232,960 4,000 Aug 30 04:03 PM BEGLEY CHRISTOPHER B Director Aug 28 '23 Buy 117.11 1,000 117,114 3,540 Sep 29 04:05 PM MICHELSON MICHAEL W Director Aug 25 '23 Buy 115.50 1,300 150,150 3,385 Aug 29 06:57 PM BERNARD BETSY J Director Aug 25 '23 Buy 114.84 871 100,023 5,271 Aug 29 06:51 PM HIGGINS ARTHUR J Director Aug 23 '23 Buy 115.61 1,000 115,613 3,400 Aug 25 04:31 PM VAN ZUILEN WILFRED Pres, Europe, M. East & Africa Jul 01 '23 Option Exercise 0.00 2,633 0 5,073 Jul 05 04:07 PM Upadhyay Suketu Exec. VP, CFO Jul 01 '23 Option Exercise 0.00 3,768 0 14,660 Jul 05 04:10 PM Stellato Paul A VP, Controller & CAO Jun 01 '23 Option Exercise 0.00 628 0 678 Jun 05 04:03 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite